Brimonidine Tartrate/Timolol Maleate

酒石酸溴莫尼定/马来酸噻吗洛尔

Report date: 2026/04/24 20:01:59

Base Information

Drug NameBrimonidine Tartrate/Timolol Maleate
Drug Alias Name马来酸噻吗洛尔/酒石酸溴莫尼定Brimonidine/timololTimolol Maleate/Brimonidine Tartrate酒石酸溴莫尼定马来酸噻吗洛尔Brimonidine Tartrate and Timolol Maleate +[11] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors alpha-2 agonistsBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptorsAdrenergic receptors alpha-2
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsGlaucomaOcular Hypertension
Approved Indications in ChinaOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2007/10/30
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsYes Brimonidine TartrateTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie IncTakeda Pharmaceutical Co LtdAllergan Pharmaceuticals Ireland Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksWikipediaKEGG